Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics

Article English OPEN
Simpson, Siobhan ; Dunning, Mark D. ; de Brot, Simone ; Grau-Roma, Llorenc ; Mongan, Nigel P. ; Rutland, Catrin S. (2017)
  • Publisher: BioMed Central
  • Journal: Acta Veterinaria Scandinavica, volume 59 (issn: 1751-0147, eissn: 1751-0147)
  • Related identifiers: pmc: PMC5655853, doi: 10.1186/s13028-017-0341-9
  • Subject: Molecular diagnostics | Treatment | Diagnostics | Genetics | Review | Bone cancer | Canine | Molecular | Veterinary medicine | SF600-1100 | Human | Osteosarcoma

Osteosarcoma (OSA) is a rare cancer in people. However OSA incidence rates in dogs are 27 times higher than in people. Prognosis in both species is poor, with five year osteosarcoma survival rates in people not having improved in decades. For dogs, one year survival rates are only around ~45%. Improved and novel treatment regimens are urgently required to improve survival in both humans and dogs with OSA. Utilising information from genetic studies could assist in this in both species, with the higher incidence rates in dogs contributing to the dog population being a good model of human disease. This review compares the clinical characteristics, gross morphology and histopathology, aetiology, epidemiology, and genetics of canine and human osteosarcoma. Finally, the current position of canine osteosarcoma genetic research is discussed and areas for additional work within the canine population are identified.
  • References (146)
    146 references, page 1 of 15

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5-29.

    2. World Health Organisation. Noncommunicable diseases country profiles 2014. eam/10665/128038/1/9789241507509_eng.pdf (2014). Accessed 28 May 2017.

    3. Bonnett B, Egenvall A, Hedhammar A, Olson P. Mortality in over 350,000 insured Swedish dogs from 1995-2000: I. Breed‑, gender ‑, age ‑ and cause‑specific rates. Acta Vet Scand. 2005;46:105-20.

    4. DeVita VT, Chu E. A history of cancer chemotherapy. Cancer Res. 2008;68:8643-53.

    5. Grüntzig K, Graf R, Hässig M, Welle M, Meier D, Lott G, Erni D, Schenker NS, Guscetti F, Boo G, et al. The swiss canine cancer registry: a retrospective study on the occurrence of tumours in dogs in Switzerland from 1955 to 2008. J Comp Pathol. 2015;152:161-71.

    6. Ranieri G, Gadaleta CD, Patruno R, Zizzo N, Daidone MG, Hansson MG, Paradiso A, Ribatti D. A model of study for human cancer: spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapies. Crit Rev Oncol Hematol. 2013;88:187-97.

    7. Schneider R. Comparison of age, sex, and incidence rates in human and canine breast cancer. Cancer. 1970;26:419-26.

    8. Pinho SS, Carvalho S, Cabral J, Reis CA, Gärtner F. Canine tumors: a spontaneous animal model of human carcinogenesis. Transl Res. 2012;159:165-72.

    9. Page R, Baneux P, Vail D, Duda L, Olson P, Anestidou L, Dybdal N, Golab G, Shelton W, Salgaller M, Hardy C. Conduct, oversight, and ethical considerations of clinical trials in companion animals with cancer: report of a workshop on best practice recommendations. J Vet Intern Med. 2016;30:527-35.

    10. Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros MSF, Swaminathan R, Ferlay J. Cancer incidence in five continents, vol. X. IARC Scientific Publication No. 164. Lyon: International Agency for Research on Cancer; 2014.

  • Related Research Results (2)
  • Metrics
    views in OpenAIRE
    views in local repository
    downloads in local repository

    The information is available from the following content providers:

    From Number Of Views Number Of Downloads
    Nottingham ePrints - IRUS-UK 0 52
Share - Bookmark